These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 4279707)

  • 1. Viscoelastic properties of ligation-inhibited fibrin clots.
    Mockros LF; Roberts WW; Lorand L
    Biophys Chem; 1974 Aug; 2(2):164-9. PubMed ID: 4279707
    [No Abstract]   [Full Text] [Related]  

  • 2. Rheology of fibrin clots. II. Linear viscoelastic behavior in shear creep.
    Gerth C; Roberts WW; Ferry JD
    Biophys Chem; 1974 Oct; 2(3):208-17. PubMed ID: 4474029
    [No Abstract]   [Full Text] [Related]  

  • 3. Rheology of fibrin clots. I. Dynamic viscoelastic properties and fluid permeation.
    Roberts WW; Kramer O; Rosser RW; Nestler FH; Ferry JD
    Biophys Chem; 1974 Feb; 1(3):152-60. PubMed ID: 4425722
    [No Abstract]   [Full Text] [Related]  

  • 4. Factor XIII consumption as an indicator of thrombin generation.
    Triantaphyllopoulos DC
    J Lab Clin Med; 1974 Jul; 84(1):74-80. PubMed ID: 4833844
    [No Abstract]   [Full Text] [Related]  

  • 5. Platelet factor XIII increases the fibrinolytic resistance of platelet-rich clots by accelerating the crosslinking of alpha 2-antiplasmin to fibrin.
    Reed GL; Matsueda GR; Haber E
    Thromb Haemost; 1992 Sep; 68(3):315-20. PubMed ID: 1279832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrin digestion by thrombin. Comparison with plasmin-digested fibrinogen.
    Kang EP; Triantaphyllopoulos DC
    Biochim Biophys Acta; 1977 Feb; 490(2):430-42. PubMed ID: 138448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clots of beta-fibrin. Viscoelastic properties, temperature dependence of elasticity, and interaction with fibrinogen-binding tetrapeptides.
    Shimizu A; Ferry JD
    Biophys J; 1988 Mar; 53(3):311-8. PubMed ID: 3349127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A physical standard of fibrinogen: measurement of the elastic modulus of dilute fibrin gels with a new elastometer.
    Carr ME; Shen LL; Hermans J
    Anal Biochem; 1976 May; 72():202-11. PubMed ID: 942048
    [No Abstract]   [Full Text] [Related]  

  • 9. Fibrinogen depletion after plasma-dilution: impairment of proteolytic resistance and reversal via clotting factor concentrates.
    He S; Johnsson H; Zabczyk M; Hultenby K; Wallén H; Blombäck M
    Thromb Haemost; 2014 Mar; 111(3):417-28. PubMed ID: 24196490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A review of the basic mechanisms of fibrinogen to fibrin conversion and of fibrinolysis: intravascular coagulation versus primary fibrinolysis.
    Colick JA; Fisher LM
    Va Med Mon (1918); 1970 May; 97(5):310-4 passimass. PubMed ID: 4276992
    [No Abstract]   [Full Text] [Related]  

  • 11. A fibrinogen concentrate Haemocomplettan (Riastap) or a Factor XIII concentrate Fibrogammin combined with a mini dose of tranexamic acid can reverse the fibrin instability to fibrinolysis induced by thrombin- or FXa-inhibitor.
    He S; Johnsson H; Zabczyk M; Hultenby K; Cao H; Blombäck M
    Br J Haematol; 2013 Mar; 160(6):806-16. PubMed ID: 23360261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Viscoelastic properties of fibrin clots.
    Roberts WW; Lorand L; Mockros LF
    Biorheology; 1973 Mar; 10(1):29-42. PubMed ID: 4724175
    [No Abstract]   [Full Text] [Related]  

  • 13. STUDIES ON THE RELATIONSHIP BETWEEN FIBRIN-STABILIZING FACTOR, CALCIUM AND INHIBITION OF FIBRINOLYSIS.
    TYLER HM; LACK CH
    Clin Sci; 1965 Jun; 28():527-36. PubMed ID: 14316258
    [No Abstract]   [Full Text] [Related]  

  • 14. Cross-linking of alpha 2-plasmin inhibitor to fibrin by fibrin-stabilizing factor.
    Sakata Y; Aoki N
    J Clin Invest; 1980 Feb; 65(2):290-7. PubMed ID: 6444305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cleavage of blood coagulation factor XIII and fibrinogen by thrombin during in vitro clotting.
    Greenberg CS; Miraglia CC; Rickles FR; Shuman MA
    J Clin Invest; 1985 May; 75(5):1463-70. PubMed ID: 2860124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New method to prepare autologous fibrin glue on demand.
    Alston SM; Solen KA; Broderick AH; Sukavaneshvar S; Mohammad SF
    Transl Res; 2007 Apr; 149(4):187-95. PubMed ID: 17383592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defective alpha-polymerization in the conversion of fibrinogen Baltimore to fibrin.
    Brown CH; Crowe MF
    J Clin Invest; 1975 Jun; 55(6):1190-4. PubMed ID: 1133167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rheological properties of fibrin clots. Effects of fibrinogen concentration, Factor XIII deficiency, and Factor XIII inhibition.
    Glover CJ; McIntire LV; Brown CH; Natelson EA
    J Lab Clin Med; 1975 Oct; 86(4):644-56. PubMed ID: 1176815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanical and Biochemical Role of Fibrin Within a Venous Thrombus.
    Chandrashekar A; Singh G; Jonah Garry ; Sikalas N; Labropoulos N
    Eur J Vasc Endovasc Surg; 2018 Mar; 55(3):417-424. PubMed ID: 29336975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The dissolution of human cross-linked plasma fibrin clots by the equimolar human plasmin-derived light (B) chain-streptokinase complex. The acceleration of clot lysis by pretreatment of fibrin clots with the light (B) chain.
    Summaria L; Boreisha IG; Arzadon L; Robbins KC
    Thromb Res; 1977 Sep; 11(3):377-89. PubMed ID: 144332
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.